Preventing kidney injury after heart surgery with RenalGuard
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests a device called RenalGuard to see if it can prevent acute kidney injury in people having heart surgery. If you are at higher risk for kidney problems, this treatment might help protect your kidneys during and after surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for heart surgery that uses a heart-lung machine (like bypass surgery or valve repair).
- You have at least one risk factor for kidney injury, such as reduced kidney function, diabetes, anemia, or a high surgical risk score.
- You are not on dialysis and do not have an emergency surgery.
- You are not taking high doses of water pills (diuretics) and can have a urinary catheter placed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood or urine markers can predict kidney problems in people having high-risk heart surgery. The goal is to find early warning signs so doctors can take steps to protect your kidneys.
This study looks at blood and urine markers in patients at higher risk for developing kidney problems after heart surgery. By identifying who is most vulnerable, doctors hope to better predict and prevent serious kidney complications.
This study looks at why some people develop kidney damage after heart surgery that uses a heart-lung machine. It aims to help doctors better predict and prevent this complication.
This study looks at how well the kidneys and body handle stress during heart surgery. By checking blood tests before and after the operation, researchers aim to find ways to protect kidney function.
This study tests a new drug (ENN0403) given during heart surgery to see if it prevents acute kidney injury—a sudden drop in kidney function. The trial is for people who are already at higher risk due to their specific heart surgery and other health factors.
This trial tests a drug called SP16 to see if it can prevent acute kidney injury in people with chronic kidney disease who are having elective heart surgery with a heart-lung machine. It aims to help preserve kidney function after surgery.
Hear when a new Cardiac Surgery Associated - Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.